164 related articles for article (PubMed ID: 20046059)
21. Immune abnormality in relation to nonimmune diseases in SAM mice.
Hosono M; Hanada K; Toichi E; Naiki H; Higuchi K; Hosokawa T
Exp Gerontol; 1997; 32(1-2):181-95. PubMed ID: 9088915
[TBL] [Abstract][Full Text] [Related]
22. Genetic typing of the senescence-accelerated mouse (SAM) strains with microsatellite markers.
Xia C; Higuchi K; Shimizu M; Matsushita T; Kogishi K; Wang J; Chiba T; Festing MF; Hosokawa M
Mamm Genome; 1999 Mar; 10(3):235-8. PubMed ID: 10051317
[TBL] [Abstract][Full Text] [Related]
23. Senile cardiac amyloidosis in senescence accelerated mouse (SAM).
Ogawa H
Jpn Circ J; 1988 Dec; 52(12):1377-83. PubMed ID: 3241319
[TBL] [Abstract][Full Text] [Related]
24. Impaired motor function in senescence-accelerated mouse prone 1 (SAMP1).
Aoyama Y; Kim TY; Yoshimoto T; Niimi K; Takahashi E; Itakura C
Brain Res; 2013 Jun; 1515():48-54. PubMed ID: 23583482
[TBL] [Abstract][Full Text] [Related]
25. The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model.
Chiba Y; Shimada A; Kumagai N; Yoshikawa K; Ishii S; Furukawa A; Takei S; Sakura M; Kawamura N; Hosokawa M
Neurochem Res; 2009 Apr; 34(4):679-87. PubMed ID: 18688709
[TBL] [Abstract][Full Text] [Related]
26. Accelerated aging of dermal fibroblast-like cells from senescence-accelerated mouse (SAM). 1. Acceleration of population aging in vitro.
Hosokawa M; Ashida Y; Nishikawa T; Takeda T
Mech Ageing Dev; 1994 May; 74(1-2):65-77. PubMed ID: 7934209
[TBL] [Abstract][Full Text] [Related]
27. Morphological analysis of skin in senescence-accelerated mouse P10.
Luo Y; Toyoda M; Nakamura M; Morohashi M
Med Electron Microsc; 2002 Mar; 35(1):31-45. PubMed ID: 12111405
[TBL] [Abstract][Full Text] [Related]
28. [SAM (Senescence Accelerated Mice) as a model for studying the ageing and age associated diseases (from II Int. Meeting "Modern Problems of Gerontology and SAM as an aging model", July 21-23, 2003, Sapporo, Japan)].
Boldyrev AA
Adv Gerontol; 2004; 13():143-6. PubMed ID: 15490737
[TBL] [Abstract][Full Text] [Related]
29. Assessment of social interaction and anxiety-like behavior in senescence-accelerated-prone and -resistant mice.
Meeker HC; Chadman KK; Heaney AT; Carp RI
Physiol Behav; 2013 Jun; 118():97-102. PubMed ID: 23672852
[TBL] [Abstract][Full Text] [Related]
30. Senescence-Accelerated Mouse (SAM) strains have a spontaneous mutation in the Abcb1a gene.
Zhang G; Zhang B; Fu X; Tomozawa H; Matsumoto K; Higuchi K; Mori M
Exp Anim; 2008 Jul; 57(4):413-7. PubMed ID: 18633165
[TBL] [Abstract][Full Text] [Related]
31. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical studies of age-associated amyloid deposition in the joint of senescence-accelerated mouse (SAM).
Shimizu K; Higuchi K; Matsushita M; Yamamuro T; Takeda T
Z Rheumatol; 1992; 51(5):243-8. PubMed ID: 1476009
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular biomarkers indicate precocious in vitro senescence in fibroblasts from SAMP6 mice. Evidence supporting a murine model of premature senescence and osteopenia.
Lecka-Czernik B; Moerman EJ; Shmookler Reis RJ; Lipschitz DA
J Gerontol A Biol Sci Med Sci; 1997 Nov; 52(6):B331-6. PubMed ID: 9402934
[TBL] [Abstract][Full Text] [Related]
34. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
35. Reduced coenzyme Q10 supplementation decelerates senescence in SAMP1 mice.
Yan J; Fujii K; Yao J; Kishida H; Hosoe K; Sawashita J; Takeda T; Mori M; Higuchi K
Exp Gerontol; 2006 Feb; 41(2):130-40. PubMed ID: 16387461
[TBL] [Abstract][Full Text] [Related]
36. Early attenuation of long-term potentiation in senescence-accelerated mouse prone 8.
Taniguchi S; Mizuno H; Kuwahara M; Ito K
Exp Brain Res; 2015 Nov; 233(11):3145-52. PubMed ID: 26195169
[TBL] [Abstract][Full Text] [Related]
37. An alternative model for studying age-associated metabolic complications: Senescence-accelerated mouse prone 8.
Liu HW; Chan YC; Wei CC; Chen YA; Wang MF; Chang SJ
Exp Gerontol; 2017 Dec; 99():61-68. PubMed ID: 28843510
[TBL] [Abstract][Full Text] [Related]
38. A novel murine model of aging, Senescence-Accelerated Mouse (SAM).
Takeda T; Hosokawa M; Higuchi K; Hosono M; Akiguchi I; Katoh H
Arch Gerontol Geriatr; 1994; 19(2):185-92. PubMed ID: 15374284
[TBL] [Abstract][Full Text] [Related]
39. Age-related changes in blood pressure in the senescence-accelerated mouse (SAM): aged SAMP1 mice manifest hypertensive vascular disease.
Han J; Hosokawa M; Umezawa M; Yagi H; Matsushita T; Higuchi K; Takeda T
Lab Anim Sci; 1998 Jun; 48(3):256-63. PubMed ID: 10090025
[TBL] [Abstract][Full Text] [Related]
40. Aged garlic extract prolongs longevity and improves spatial memory deficit in senescence-accelerated mouse.
Moriguchi T; Saito H; Nishiyama N
Biol Pharm Bull; 1996 Feb; 19(2):305-7. PubMed ID: 8850329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
